25 companies in this supply chain, sorted by market share.
Brescia, Lombardy-based manufacturer that invented and patented flocked nasopharyngeal swab technology (FLOQSwab, 2003). Pre-COVID held ~50% of global NP swab supply. Located in the Lombardy region — the first European COVID epicenter — creating a catastrophic supply chain disruption when their workers were among the first hospitalized.
Supplies these inputs
Nasopharyngeal Flocked Nylon Swabs
Replaceability
Substitutability 20% · 12 mo to replace
Business segments
- FLOQSwab® Flocked Nasopharyngeal & Specimen Swabs55% rev
- Transport Media (UTM / VTM / ESwab)25% rev
- WASPLab® Automated Microbiology (Robotics)15% rev
- Specialty Diagnostics & Forensics5% rev
Life sciences tools and services business of Danaher Corporation (NYSE: DHR); formed from the 2019 GE Healthcare Life Sciences acquisition; produces Vivid® lateral flow nitrocellulose membranes (formerly Whatman/GE brand); market leader in lateral flow assay membranes for diagnostics; also owns the Pall filtration business; Cytiva Vivid membranes are the reference standard used in most FDA-cleared lateral flow diagnostic assays including COVID-19, pregnancy tests, and flu diagnostics; Marlborough MA headquarters
Supplies these inputs
Fluorescent Reporter Dyes & Oligonucleotide Probes · Glass Fiber Conjugate Pads & Borosilicate Fiber Membranes · Nitrocellulose (NC) Membrane for Lateral Flow
Replaceability
Substitutability 20% · 18 mo to replace
Business segments
- Lateral Flow Nitrocellulose Membranes (Vivid/Whatman)30% rev
- Pall Filtration (Industrial & Pharmaceutical)35% rev
- Bioprocessing Tools & Resins25% rev
- Cell Biology & Analytical10% rev
Family-owned manufacturer in Guilford and Pittsfield, Maine. Pre-COVID the only significant US domestic producer of flocked NP swabs. Received >$250M in combined US DoD and HHS funding to rapidly scale COVID swab production. Output scaled to millions of swabs/week during pandemic.
Supplies these inputs
Nasopharyngeal Flocked Nylon Swabs
Replaceability
Substitutability 25% · 12 mo to replace
Business segments
- Flocked Diagnostic Swabs (NP/OP/Nasal)55% rev
- Traditional Cotton & Foam Applicators30% rev
- Forensic & Law Enforcement Collection10% rev
- Veterinary & Environmental Testing5% rev
QIAGEN NV (Venlo, Netherlands; operational HQ Hilden, Germany); market leader in DNA/RNA extraction kits with 22-26% global share; flagship QIAamp Viral RNA Mini Kit is the WHO-recommended standard for respiratory virus testing including SARS-CoV-2; manufacturing in Hilden (Germany), Barcelona (Spain), Germantown MD (USA), and Suzhou (China); in March 2020 Qiagen operated 3 shifts/7 days to meet COVID demand at Hilden and Barcelona; Thermo Fisher attempted $11.5B acquisition in 2020 but withdrew in August 2020; Qiagen remains independent with a partial stake held by Danaher
Supplies these inputs
RNA Extraction Kit Components (Silica Columns, Chaotropic Salts) · Taq DNA Polymerase & Reverse Transcriptase (RT) Enzymes
Replaceability
Substitutability 30% · 6 mo to replace
Business segments
- Sample Technologies — DNA/RNA Extraction Kits45% rev
- Molecular Diagnostics & PCR30% rev
- Forensic Genomics12% rev
- Bioinformatics & Clinical Interpretation13% rev
Washington DC-based conglomerate that owns Cytiva (Whatman brand — nitrocellulose membranes, glass fiber pads), IDT (oligonucleotide probes), and Pall Corporation (filtration). Controls an extraordinary concentration of IVD supply chain chokepoints through acquisitions across multiple independent critical nodes.
Supplies these inputs
Glass Fiber Conjugate Pads & Borosilicate Fiber Membranes · Nitrocellulose (NC) Membrane for Lateral Flow
Business segments
- Cytiva (GE Healthcare Life Sciences) — Bioprocess35% rev
- Pall Corporation (Industrial & Lab Filtration)25% rev
- IDT (Integrated DNA Technologies) — Oligonucleotides & CRISPR15% rev
- Diagnostics (Beckman Coulter, Cepheid)25% rev
German life sciences company that manufactured the world's first industrial nitrocellulose membrane in 1960 in Göttingen. Its Unisart® CN series is one of the two dominant global LFA membrane brands. Key OEM supplier to virtually every major rapid test manufacturer.
Supplies these inputs
Nitrocellulose (NC) Membrane for Lateral Flow
Replaceability
Substitutability 25% · 18 mo to replace
Business segments
- Bioprocess Solutions (Single-Use Bioreactors & Filtration)58% rev
- Nitrocellulose Membranes (Lateral Flow Assay)12% rev
- Lab Products & Precision Instruments30% rev
Thermo Fisher Scientific (Waltham MA; NYSE: TMO; ~$43B revenue 2024) is the world's largest manufacturer of cell culture media through its Gibco brand — the dominant label in CHO (Chinese Hamster Ovary) cell culture media for biopharmaceutical manufacturing. Gibco CHO-S Serum-Free Medium, GlutaMAX supplement, CD CHO medium, and EX-CELL Advanced CHO media series supply the majority of global monoclonal antibody manufacturing processes. Thermo Fisher's cell culture media is manufactured primarily at its Grand Island, NY facility (acquired from Life Technologies, itself formerly GIBCO BRL), which is the single most important cell culture media manufacturing site in North America. Thermo Fisher also operates a major media production site in Paisley, Scotland (UK) that serves European biopharmaceutical manufacturing. Gibco media formulations are validated into more FDA-approved biologics manufacturing processes than any other supplier — creating regulatory lock-in equivalent to Cytiva's position in chromatography resins. The 2014 Thermo Fisher merger with Life Technologies (which itself had acquired Invitrogen in 2008 and GIBCO BRL in 2000) consolidated what were once multiple competing cell culture brands into a single dominant supplier.
Supplies these inputs
Fluorescent Reporter Dyes & Oligonucleotide Probes · RNA Extraction Kit Components (Silica Columns, Chaotropic Salts) · Taq DNA Polymerase & Reverse Transcriptase (RT) Enzymes
Replaceability
Substitutability 30% · 6 mo to replace
Business segments
- Life Sciences Solutions40% rev
- Analytical Instruments25% rev
- Laboratory Products & Services25% rev
- Specialty Diagnostics10% rev
German multinational producing the Hi-Flow Plus nitrocellulose membrane — one of the two industry-standard LFA membranes globally. Received a €121M US DoD/HHS contract to build the first US lateral flow membrane facility in Sheboygan, WI (2022) to reduce concentration risk in Cork, Ireland.
Supplies these inputs
Fluorescent Reporter Dyes & Oligonucleotide Probes · Glass Fiber Conjugate Pads & Borosilicate Fiber Membranes · Nitrocellulose (NC) Membrane for Lateral Flow
Replaceability
Substitutability 25% · 4 mo to replace
Business segments
- Life Science (MilliporeSigma — US Brand)42% rev
- Healthcare (Pharma — Small Relative to Life Science)22% rev
- Electronics / Performance Materials (Liquid Crystals & OLED)28% rev
- Surface Solutions & Specialty Chemicals8% rev
UK-based manufacturer of gold colloid and lateral flow assay reagents; headquartered in Crumlin, South Wales; ISO 13485:2015 certified; supplies gold nanoparticles used in over 500 million diagnostic assays globally per year; pioneer in commercial colloidal gold production for 30+ years; offers proprietary large-batch manufacturing with high particle uniformity; acquired IBEX Technologies (Canada) in 2024 and Biotez GmbH (Germany) to expand biochemistry capabilities; key supplier to Roche, Abbott, Siemens Healthineers and other major IVD manufacturers
Supplies these inputs
Colloidal Gold Nanoparticles (AuNPs)
Replaceability
Substitutability 35% · 12 mo to replace
Business segments
- Colloidal Gold (Diagnostic Grade)55% rev
- Lateral Flow Assay Components30% rev
- Biochemistry (IBEX, Biotez)
Danaher subsidiary (acquired 2020 as part of the $21.4B GE Healthcare Life Sciences deal); world's largest custom oligonucleotide manufacturer; makes fluorescent-labeled TaqMan-compatible probes using proprietary Freedom Dyes portfolio (patent-free Cy dye alternatives); Coralville IA HQ; expanded GMP therapeutic oligo manufacturing 2023
Supplies these inputs
Fluorescent Reporter Dyes & Oligonucleotide Probes
Replaceability
Substitutability 45% · 6 mo to replace
Business segments
- Custom DNA Oligonucleotides (Research)40% rev
- CRISPR & Gene Editing Tools25% rev
- NGS & Library Prep20% rev
- RNA & Functional Oligos15% rev
Cincinnati, Ohio-based company and one of the world's largest OEM suppliers of diagnostic enzymes and antibodies. Offers 3,000+ antigens and antibodies covering 500+ diseases plus comprehensive PCR enzyme portfolio. Many IVD manufacturers depend on Meridian as a hidden sole-source OEM supplier — a chokepoint invisible to end users.
Supplies these inputs
Taq DNA Polymerase & Reverse Transcriptase (RT) Enzymes
Replaceability
Substitutability 40% · 9 mo to replace
Business segments
- PCR Enzymes (OEM Backbone of Molecular Diagnostics)35% rev
- Diagnostic Antibodies & Antigens (IVD OEM)40% rev
- Finished Diagnostic Tests (Internal Brand)20% rev
- Maravai / Meridian Overlap & Structure5% rev
Finnish biotechnology company (Turku, Finland); specialist manufacturer of diagnostic monoclonal antibodies for cardiac biomarkers; introduced the first anti-cardiac troponin I (cTnI) monoclonal antibodies to market in 1994; supplier to virtually every major cardiac diagnostic test maker (Abbott, Roche, Siemens Healthineers, Beckman Coulter); acquired by Mindray Medical (China's largest medical device company) in 2016 for an undisclosed sum; Mindray ownership means Chinese corporate control of the dominant non-Chinese supplier of troponin I capture antibodies — the gold standard biomarker for myocardial infarction diagnosis
Supplies these inputs
Diagnostic-Grade Monoclonal Antibodies (mAbs)
Replaceability
Substitutability 20% · 24 mo to replace
Business segments
- Cardiac Biomarker Antibodies65% rev
- Infectious Disease Antibodies20% rev
- Other Diagnostic Components15% rev
Diagnostic division of F. Hoffmann-La Roche (Basel, Switzerland); manufactures viral RNA extraction kits including the High Pure Viral RNA Kit and MagNA Pure series; integrated with Roche cobas PCR system for automated end-to-end COVID testing; ~10-12% of RNA extraction kit market; manufacturing in Mannheim, Germany (primary) and Penzberg, Bavaria; FDA approved the Roche extraction kit as an alternative to Qiagen during COVID, but Roche was also on backorder simultaneously
Supplies these inputs
RNA Extraction Kit Components (Silica Columns, Chaotropic Salts) · Taq DNA Polymerase & Reverse Transcriptase (RT) Enzymes
Replaceability
Substitutability 35% · 8 mo to replace
Business segments
- Molecular Diagnostics (PCR, NGS)35% rev
- Tissue Diagnostics (Pathology)20% rev
- Clinical Chemistry & Immunoassay25% rev
- Point of Care10% rev
Chinese biotechnology CRO/manufacturer (Beijing); specializes in recombinant protein production and monoclonal antibody development for diagnostic use; one of the world's largest suppliers of diagnostic-grade SARS-CoV-2 antibodies (spike, RBD, nucleocapsid); supplied capture and detection antibodies for COVID-19 rapid antigen tests manufactured by Western companies in 2020-2021; rapid protein and antibody development capability (weeks vs months for Western competitors) made Sino Biological the fastest-to-market supplier for novel pathogen antibodies; exports to 100+ countries
Supplies these inputs
Diagnostic-Grade Monoclonal Antibodies (mAbs)
Replaceability
Substitutability 40% · 6 mo to replace
Business segments
- Diagnostic Antigens & Antibodies (COVID + Other Pathogens)45% rev
- Research Proteins (Cytokines, Growth Factors, Checkpoints)38% rev
- CRO / Custom Development Services17% rev
Finnish specialty fiber and filtration materials company; merged with Munksjö 2017; produces ReliaFlow™ conjugate pads (8980, 6614) for lateral flow immunoassays; serves infectious disease, pregnancy, drugs-of-abuse, food safety, veterinary, and environmental LFA markets; major European alternative to Whatman/Cytiva glass fiber pads
Supplies these inputs
Glass Fiber Conjugate Pads & Borosilicate Fiber Membranes
Replaceability
Substitutability 50% · 4 mo to replace
Business segments
- Medical & Diagnostics Fiber Materials30% rev
- Filtration Materials30% rev
- Food & Beverage Filtration20% rev
- Industrial & Other Specialty20% rev
Finnish diagnostic reagent company (Kauniainen, near Helsinki, Finland); produces monoclonal and polyclonal antibodies for cardiac markers (troponin, CK-MB, myoglobin), fertility hormones (hCG, LH, FSH), infectious disease (HIV, HCV), and other IVD applications; key OEM supplier to global diagnostic companies; alongside HyTest, one of the two Finnish firms that supply the antibody backbone for most of the world's cardiac rapid tests; exports to 100+ countries
Supplies these inputs
Diagnostic-Grade Monoclonal Antibodies (mAbs)
Replaceability
Substitutability 25% · 18 mo to replace
Business segments
- Cardiac Biomarker Antibodies40% rev
- Fertility & Hormone Antibodies30% rev
- Infectious Disease & Inflammation30% rev
Indian manufacturer of nitrocellulose membranes for lateral flow diagnostics; headquartered in Ambala, Haryana, India; a major contributor to India's ~15% global NC membrane production share; supplies membrane to global rapid test manufacturers at competitive prices; one of the few non-Western qualified NC membrane suppliers; capacity expansion driven by COVID-19 demand and Indian government ambitions in global diagnostics supply chain
Supplies these inputs
Nitrocellulose (NC) Membrane for Lateral Flow
Replaceability
Substitutability 50% · 12 mo to replace
Business segments
- Nitrocellulose Membranes (Lateral Flow)80% rev
- Other Diagnostic Membranes20% rev
San Diego, California-based gold and silver nanoparticle manufacturer; acquired by Fortis Life Sciences (~2020); produces highly monodisperse gold nanoparticles for lateral flow assays, immunodiagnostics, and research; reference manufacturer for many gold NP characterization standards; known for ultra-uniform particle sizing critical for consistent assay performance; supplies to diagnostic kit developers and OEM test manufacturers globally
Supplies these inputs
Colloidal Gold Nanoparticles (AuNPs)
Replaceability
Substitutability 40% · 9 mo to replace
Business segments
- Gold Nanoparticles (Diagnostic)60% rev
- Silver Nanoparticles20% rev
- Research & Custom NPs20% rev
